Nom de l’entreprise
University of Miami Miller School of Medicine @
Education:
@
St. John's University
About:
Niven R. Narain is the President, Co-Founder and Chief Technology Officer of Berg, a biotech company applying artificial intelligence to create more holistic drug therapies and diagnostic screening tools for society’s most vexing diseases.
Co-Founder, President & CTO @ Berg focuses research on understanding how alterations in metabolism relate to disease onset. The company has a deep pipeline
Niven R. Narain is the President, Co-Founder and Chief Technology Officer of Berg, a biotech company applying artificial intelligence to create more holistic drug therapies and diagnostic screening tools for society’s most vexing diseases.
Co-Founder, President & CTO @ Berg focuses research on understanding how alterations in metabolism relate to disease onset. The company has a deep pipeline of early-stage technologies in CNS diseases and metabolic diseases that complement its late-stage clinical trial activity in cancer and prevention of chemotoxicity. Armed with use of the Berg Interrogative Biology™ discovery platform that translates biological output into therapeutic candidates, Berg is well positioned for rapid commercialization of its intellectual capital. From January 2009 to Present (7 years) Sr. Pharma Advisor @ Established in 2003, Ocean Tomo, LLC, the Intellectual Capital Merchant Banc™ firm, provides industry leading financial products and services related to intellectual property including financial expert testimony, valuation, strategy consulting, proprietary research products, investment services, risk management products, innovation management services and transaction brokerage. Ocean Tomo assists clients – corporations, law firms, governments and institutional investors – in realizing Intellectual Capital Equity® value broadly defined. From February 2009 to Present (6 years 11 months) Visiting Research Scholar @ From March 2009 to Present (6 years 10 months) Director of Cutaneous Oncology & Therapeutics Research @ Research and Development related to targets, agents, and contructs that may have an effect on skin cancers. From February 2001 to February 2009 (8 years 1 month)
University of Miami Leonard M. Miller School of MedicineSt. John's University Niven Narain is skilled in: Clinical Trials, Drug Discovery, Technology Transfer, Science, Research, Biotechnology, Entrepreneurship, Molecular Biology, Western Blotting, Bioinformatics, Oncology, Cell Culture, Analytics, Pharmaceutical Industry, Cell Biology
Websites:
http://www.berghealth.com
Looking for a different
Niven Narain?
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension